David Campbell
Direttore/Membro del Consiglio presso SYNAIRGEN PLC
Patrimonio netto: 29 170 $ in data 31/05/2024
Posizioni attive di David Campbell
Società | Posizione | Inizio | Fine |
---|---|---|---|
SYNAIRGEN PLC | Direttore/Membro del Consiglio | 29/09/2009 | - |
iQur Ltd.
iQur Ltd. BiotechnologyHealth Technology iQur Ltd. develops vaccines based on tandem core vaccine technology. The firm offers fibrosis assessment in viral hepatitis and other chronic liver diseases, and developing new treatments for serious liver disease through drug discovery research programs. The company was founded by William Rosenberg on February 13, 2003 and is headquartered in London, the United Kingdom. | Presidente | 01/01/2005 | - |
Storia della carriera di David Campbell
Precedenti posizioni note di David Campbell
Società | Posizione | Inizio | Fine |
---|---|---|---|
Proximagen Group Plc
Proximagen Group Plc Miscellaneous Commercial ServicesCommercial Services Proximagen Group Plc engages in the business of discovery and development of therapeutic treatments. The company was founded by Jenner Peter on November 2003 and is headquartered in Cambridge, the United Kingdom. | Direttore/Membro del Consiglio | - | 29/01/2010 |
Modern Biosciences Ltd.
Modern Biosciences Ltd. Pharmaceuticals: MajorHealth Technology Part of Istesso Ltd., Modern Biosciences Ltd. is a British pharmaceutical company that manufactures pharmaceutical products. The company is based in London, UK. The company was founded by Samuel Cameron Williams, Alexander James Stevenson. Samuel Cameron Williams has been the CEO since incorporation. | Direttore/Membro del Consiglio | 25/11/2010 | - |
Servier Laboratories Ltd.
Servier Laboratories Ltd. Pharmaceuticals: MajorHealth Technology Servier Laboratories Ltd. develops and manufactures pharmaceuticals. Its product portfolio includes Lonsurf, Oncaspar, Pixuvri, Valdoxan, and Natrilix. The company was founded in 1964 and is headquartered in Stoke Poges, the United Kingdom. | Direttore Tecnico/Scientifico/R&S | - | - |
NEUROCRINE BIOSCIENCES, INC. | Corporate Officer/Principal | - | - |
Drug Information Association
Drug Information Association Miscellaneous Commercial ServicesCommercial Services The Drug Information Association is a non-profit multidisciplinary association that operates to promote health and well-being. The non-profit company is based in Horsham, PA. Marwan Fathallah has been the CEO of the company since 2023. | Presidente | - | - |
BenevolentAI Cambridge Ltd.
BenevolentAI Cambridge Ltd. Miscellaneous Commercial ServicesCommercial Services BenevolentAI Cambridge Ltd. develops novel small molecule therapeutics, in particular in the areas of CNS, pain and inflammation. It specializes in drug development, project management and translational medicine. The company was founded on November 26, 2003 and is headquartered in London, the United Kingdom. | Direttore/Membro del Consiglio | - | - |
IP GROUP PLC | Direttore Tecnico/Scientifico/R&S | - | - |
Statistiche
Distribuzione geografica
Regno Unito | 8 |
Stati Uniti | 3 |
Posizioni
Director/Board Member | 4 |
Chairman | 2 |
Chief Tech/Sci/R&D Officer | 2 |
Settori
Health Technology | 6 |
Commercial Services | 5 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 3 |
---|---|
IP GROUP PLC | Commercial Services |
NEUROCRINE BIOSCIENCES, INC. | Health Technology |
SYNAIRGEN PLC | Health Technology |
Aziende private | 6 |
---|---|
Proximagen Group Plc
Proximagen Group Plc Miscellaneous Commercial ServicesCommercial Services Proximagen Group Plc engages in the business of discovery and development of therapeutic treatments. The company was founded by Jenner Peter on November 2003 and is headquartered in Cambridge, the United Kingdom. | Commercial Services |
iQur Ltd.
iQur Ltd. BiotechnologyHealth Technology iQur Ltd. develops vaccines based on tandem core vaccine technology. The firm offers fibrosis assessment in viral hepatitis and other chronic liver diseases, and developing new treatments for serious liver disease through drug discovery research programs. The company was founded by William Rosenberg on February 13, 2003 and is headquartered in London, the United Kingdom. | Health Technology |
BenevolentAI Cambridge Ltd.
BenevolentAI Cambridge Ltd. Miscellaneous Commercial ServicesCommercial Services BenevolentAI Cambridge Ltd. develops novel small molecule therapeutics, in particular in the areas of CNS, pain and inflammation. It specializes in drug development, project management and translational medicine. The company was founded on November 26, 2003 and is headquartered in London, the United Kingdom. | Commercial Services |
Drug Information Association
Drug Information Association Miscellaneous Commercial ServicesCommercial Services The Drug Information Association is a non-profit multidisciplinary association that operates to promote health and well-being. The non-profit company is based in Horsham, PA. Marwan Fathallah has been the CEO of the company since 2023. | Commercial Services |
Servier Laboratories Ltd.
Servier Laboratories Ltd. Pharmaceuticals: MajorHealth Technology Servier Laboratories Ltd. develops and manufactures pharmaceuticals. Its product portfolio includes Lonsurf, Oncaspar, Pixuvri, Valdoxan, and Natrilix. The company was founded in 1964 and is headquartered in Stoke Poges, the United Kingdom. | Health Technology |
Modern Biosciences Ltd.
Modern Biosciences Ltd. Pharmaceuticals: MajorHealth Technology Part of Istesso Ltd., Modern Biosciences Ltd. is a British pharmaceutical company that manufactures pharmaceutical products. The company is based in London, UK. The company was founded by Samuel Cameron Williams, Alexander James Stevenson. Samuel Cameron Williams has been the CEO since incorporation. | Health Technology |
- Borsa valori
- Insiders
- David Campbell
- Esperienza